Wegovy costs $269–$460/month in Australia. Full price by dose from 0.25mg to 2.4mg, PBS listing status, first-year total cost, and free dose tracking.
Download on the App StoreAt the maintenance dose of 2.4mg weekly, Wegovy typically costs $350 to $450 per month on a private prescription. During the escalation phase (months 1–4) costs range from approximately $180 to $290 per month depending on the current dose stage.
No. Wegovy is not PBS-listed for weight loss, so Medicare does not subsidise it. You pay the full private price regardless of your health fund or concession status.
Yes. Wegovy is TGA-approved and available on private prescription for adults with a BMI of 30 or above, or 27 or above with a qualifying weight-related health condition.
GPs experienced in weight management, endocrinologists, and licensed telehealth obesity medicine clinics can all prescribe Wegovy. A standard GP who is not experienced in weight management may refer you to a specialist.
If Wegovy receives PBS listing for weight management, the cost would drop significantly for eligible patients. As of mid-2026, no such listing has been approved, though it remains under active policy consideration.
For patients with type 2 diabetes, Ozempic on a PBS prescription is the most cost-effective route at approximately $42 per month. For weight management without a diabetes diagnosis, a private semaglutide prescription (Wegovy or compounded semaglutide if available) is the pathway — with prices varying between pharmacies.
Mounjaro (tirzepatide) is broadly comparable to Wegovy in private prescription cost in Australia — approximately $350 to $500 per month at therapeutic doses. Clinical trials have shown greater average weight loss with Mounjaro than with semaglutide, which some patients weigh against the similar price.